TY  - PAT 
AU  - Carretero Coca, Rafael
PY  - 2014
UR  - https://hdl.handle.net/10481/107802
AB  - The present invention refers to a method of predicting or prognosticating the response of a human subject to immunotherapy (from hereinafter method of the invention), wherein the subject is suffering from a cancer disease, and wherein the method...
LA  - eng
PB  - WIPO (PCT)
KW  - beta2-microglobulin
KW  - B2m
KW  - Immunotherapy
KW  - Biomarker
KW  - Cancer
KW  - Gene therapy
TI  - Expression of beta2-microglobulin as a prognostic marker for tumour immune escape and resistance to cancer immunotherapy and a diagnostic biomarker for patient selection for specific gene therapy
ER  -